Approval · Notice of Compliance 32221 · 2023
OMNISCAN: Notice of Compliance 32221
Issued November 30, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 32221
- Date
- November 30, 2023
- Company
- Ge Healthcare Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Response to advisement letter and conversion of the Product Monograph to the Master Template.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OMNISCAN | Not yet assigned | — |
Medicinal ingredients
- GADODIAMIDE 287 MG per ML